期刊
EXPERT OPINION ON PHARMACOTHERAPY
卷 12, 期 8, 页码 1333-1340出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14656566.2011.580739
关键词
antidepressant; arthritis; back pain; clinically meaningful; osteoarthritis
Introduction: Antidepressants offer substantial analgesic benefits for a wide range of chronic pain conditions. Areas covered: The serotonin-norepinephrine reuptake inhibitor, duloxetine, is well established for reducing pain in patients with diabetic neuropathy and fibromyalgia. Indications were recently expanded also to include the treatment of chronic musculoskeletal pain related to osteoarthritis and chronic low back pain. In addition, animal studies and postoperative pain data indicate possible additional uses of duloxetine for the management of acute pain. Expert opinion: Antidepressants, such as duloxetine, offer a valuable therapy for patients with chronic pain, regardless of whether comorbid mood disorders are present or not. Clinicians must set reasonable expectations for anticipated improvements with duloxetine. In general, a 30% improvement in average nonmalignant pain severity represents a clinically meaningful improvement target. About 50 - 60% of patients with chronic osteoarthritis or chronic low back pain treated with 60 - 120 mg duloxetine daily can expect this level of improvement.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据